Aramis: Efficacy and safety of darolutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC).

K Fizazi, ND Shore, T Tammela, A Ulys, E Vjaters, S Polyakov, M Jievaltas, M Luz, BY Alekseev, I Kuss, C Kappeler, A Snapir, T Sarapohja, MR Smith

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number140
Number of pages2
JournalJournal of Clinical Oncology
Issue number7 Suppl.
Publication statusPublished - 1 Mar 2019
Externally publishedYes
Event2019 Genitourinary Cancers Symposium - San Francisco, United States
Duration: 14 Feb 201916 Feb 2019

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this